Comparison

Linperlisib European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 25 mg
Item no. HY-102031-25mg
Targets PI3K
CASRN 1702816-75-8
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
Molecular Weight
588.69
Clinical Information
Phase 2
Solubility
DMSO : 100 mg/mL (ultrasonic)
Isoform
PI3Kδ
Pathway
PI3K/Akt/mTOR
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close